CTS Corporation (CTS) Bundle
You've been tracking CTS Corporation's (CTS) strategic shift, but the real question is whether the smart money is buying the story, and honestly, the investor profile is a mixed bag that demands a closer look. The institutional holding is massive, with over 91% of the company's shares held by funds, including giants like BlackRock, Inc. and Vanguard Group Inc.. But here's the rub: while the company is guiding for full-year 2025 sales between $535 million and $545 million and just announced a new $100 million share repurchase plan to boost returns, some major holders are pulling back; BlackRock, Inc. recently decreased its position by 12.51%. So, with Q3 2025 sales hitting $143 million-driven by a 22% jump in diversified markets like Medical and Industrial-are the sellers worried about the declining Transportation segment, or are the buyers banking on that 59% diversified revenue mix to drive future growth and prove the stock is defintely undervalued at its current price?. That's the core tension we need to unpack.
Who Invests in CTS Corporation (CTS) and Why?
The investor base for CTS Corporation (CTS) is overwhelmingly dominated by large institutions, which own the vast majority of the company's shares. This institutional confidence is driven by CTS Corporation's strategic shift toward diversification and its commitment to returning capital, even as its traditional transportation market faces near-term headwinds.
As of the 2025 fiscal year, institutional investors hold a commanding position, accounting for approximately 89.64% to 97.03% of the outstanding shares. This leaves a small float for other investors, including company insiders (around 2.15% to 2.77%) and retail investors, who collectively hold the remainder. This high institutional ownership suggests that the stock's price movements are heavily influenced by the large-scale investment decisions of major funds, not individual trading activity.
Here's the quick math on the ownership distribution:
- Institutional Investors: ~91.6%
- Retail/Other Investors: ~8.4%
- Insiders: ~2.77%
Key Investor Types and Their Dominance
The institutional landscape for CTS Corporation (CTS) is a mix of passive index funds, large mutual funds, and active asset managers. These are the players who truly move the needle.
The largest shareholders are global asset management giants like BlackRock, Inc. and Vanguard Group Inc. BlackRock, Inc., for instance, holds about 15.27% of the company's shares, totaling approximately 4.56 million shares as of June 30, 2025, valued at around $194.44 million. Vanguard Group Inc is the second-largest, holding about 9.03%, or 2.70 million shares. To be fair, a lot of this is passive investing-they own the stock because it's in an index fund, which means they are essentially permanent holders.
The table below shows the top institutional holders and their positions as of mid-2025, illustrating the concentration of ownership:
| Institution | Shares Held (Millions) | Ownership Percentage | Value (Millions USD) |
|---|---|---|---|
| BlackRock, Inc. | 4.56M | 15.27% | $194.44M |
| Vanguard Group Inc | 2.70M | 9.03% | $114.91M |
| Earnest Partners Llc | 1.98M | 6.61% | $84.20M |
| Wasatch Advisors Lp | 1.71M | 5.72% | $72.81M |
| T. Rowe Price Investment Management, Inc. | 1.65M | 5.53% | $70.44M |
Source: Data as of June 30, 2025.
Investment Motivations: The Growth and Diversification Thesis
The primary attraction for investors in CTS Corporation (CTS) is its clear, ongoing strategy of diversification away from its legacy transportation business into higher-growth, more stable industrial markets. This is the core investment narrative.
The company's focus on medical, industrial, and aerospace/defense sectors is resonating, with diversified sales showing a strong 22% year-over-year growth in the third quarter of 2025, even as the transportation sector declined by 7%. Management is guiding for full-year 2025 sales in the range of $535 million to $545 million, with an adjusted diluted EPS of $2.20 to $2.25, reflecting confidence in this strategic pivot. Also, the company's commitment to shareholder returns is a major draw. CTS Corporation (CTS) returned $44 million to shareholders in 2025 through its ongoing share repurchase program, which has bought back 5.82% of shares outstanding since early 2024.
- Growth Prospects: Expansion into non-transportation markets like medical and aerospace/defense.
- Capital Allocation: Strong cash flow generation and a commitment to share repurchases.
- Product Innovation: Introduction of new products like the eBrake™ for the commercial vehicle market.
Investment Strategies in Play
You see three main strategies at work among CTS Corporation (CTS) investors: passive indexing, active growth, and a tactical, value-oriented approach.
The sheer size of holdings by BlackRock, Inc. and Vanguard Group Inc points to a dominant long-term holding strategy, which is typical for index funds and large institutional mandates (Schedule 13G filings). These investors are buying the market, and CTS Corporation (CTS) is simply a component of that market. Then you have the active managers. Funds like Earnest Partners Llc, which increased its position by 20.52% in August 2025, are clearly implementing a growth investing strategy, buying into the diversification and margin expansion story. They see the long-term potential in the shift to higher-margin industrial and medical components.
On the flip side, the stock's price drop from $52.58 in November 2024 to $41.98 in November 2025 has created a potential entry point for value investors. These investors are often looking for a well-managed company with a solid balance sheet-which CTS Corporation (CTS) has-that is temporarily undervalued due to short-term market softness, such as the decline in the transportation sector. You also see evidence of short-term trading or tactical positioning, with 88 institutional investors adding shares and 100 decreasing their positions in the first quarter of 2025. That's a lot of churn, defintely indicating active management trying to time the market's reaction to the diversification progress. If you want to dive deeper into the company's foundations, you can check out CTS Corporation (CTS): History, Ownership, Mission, How It Works & Makes Money.
Institutional Ownership and Major Shareholders of CTS Corporation (CTS)
If you're looking at CTS Corporation (CTS), the first thing to understand is that it's defintely an institutionally-owned stock. A staggering 96.20% of the company's shares are held by institutional investors as of September 2025, which means the big money-the mutual funds, pension funds, and asset managers-drives the stock's action. That leaves a small float for individual investors, so any major institutional move can have an outsized impact on the share price.
The total value of these institutional holdings stood at approximately $1.17 billion as of June 30, 2025, spread across over 214 institutions. This high concentration of ownership is typical for a mid-cap technology company focused on critical engineered solutions, but it also means you need to pay close attention to the movements of the largest players.
Top Institutional Investors: Who Holds the Keys?
The investor base for CTS Corporation is dominated by some of the largest asset managers in the world, the kind of firms that hold positions for decades, not days. These are not fast-money hedge funds; they are often passive index trackers or large-scale active managers. BlackRock and Vanguard Group, the two titans of asset management, lead the pack. Here's a look at the top institutional holders based on their most recent filings from the third quarter of 2025 (Q3 2025):
- BlackRock, Inc.: Holds the largest stake with approximately 4.45 million shares as of September 30, 2025.
- Vanguard Group Inc.: A close second, holding around 2.71 million shares.
- Earnest Partners LLC: A significant active manager with about 1.87 million shares.
- Wasatch Advisors LP: Another key holder with approximately 1.79 million shares.
To give you a clearer picture of who is sitting at the top of the cap table, here's the quick math on the top five, based on June 30, 2025 data, which represents a total ownership of over 40% of the institutional holdings.
| Institution | Shares Held (Millions) | Ownership Percentage | Value (Millions) |
|---|---|---|---|
| BlackRock, Inc. | 4.56M | 15.27% | $194.44M |
| Vanguard Group Inc. | 2.70M | 9.03% | $114.91M |
| Earnest Partners LLC | 1.98M | 6.61% | $84.20M |
| Wasatch Advisors LP | 1.71M | 5.72% | $72.81M |
| T. Rowe Price Investment Management Inc. | 1.65M | 5.53% | $70.44M |
Recent Shifts: Are Institutions Buying or Selling?
The institutional picture is not static; it's a tug-of-war, and in the most recent quarter, we saw some meaningful shifts. Overall, institutional investors slightly decreased their total holdings from 96.24% to 96.20% between August and September 2025. But the real story is in the individual movements.
For example, during Q2 2025, T. Rowe Price Investment Management significantly reduced its position, removing 388,058 shares, a drop of 19.0%. That's a large, notable sale. On the flip side, Earnest Partners LLC was a big buyer, adding 336,475 shares, an increase of 20.5% to its portfolio. This tells you that while some large funds are taking profits or rebalancing, others see a compelling entry point or long-term value.
You have to look at the conviction behind the trades. The net activity shows a mixed sentiment, but the fact that 112 institutions added shares while 99 decreased their positions in a recent quarter suggests a fairly balanced debate on the stock's near-term prospects. The big money is split.
Impact on Stock Price and Corporate Strategy
Institutional investors are not passive bystanders; they are the ultimate arbiters of a company's strategy and valuation. For CTS Corporation, the high institutional ownership means management is constantly catering to the demands of these large shareholders for capital efficiency and growth.
Their influence is clear in the company's strategic focus: diversification. With the transportation sector facing headwinds, the institutional narrative is all about CTS's ability to grow in its diversified end markets-Industrial, Medical, and Aerospace & Defense. The strong Q3 2025 results, which reported a 22% year-over-year sales growth in diversified markets despite a 7% decline in transportation, directly supports this institutional thesis. The guidance for 2025 sales between $535-$545 million and adjusted diluted EPS of $2.20-$2.25 is the benchmark against which these large investors measure success.
Furthermore, on November 7, 2025, CTS Corporation announced a new US$100 million share repurchase program. This is a classic move to appease institutional investors, signaling a commitment to returning capital and supporting the stock price, especially when revenue growth is under pressure from core markets. This share buyback, alongside the declared US$0.04 per share cash dividend, is a direct action to enhance shareholder value, which is exactly what the largest holders demand. If you want to understand the company's long-term direction, you need to read the Mission Statement, Vision, & Core Values of CTS Corporation (CTS).
Key Investors and Their Impact on CTS Corporation (CTS)
The investor profile for CTS Corporation (CTS) is dominated by institutional money, which holds the vast majority of the company's shares. As a seasoned analyst, I look at this concentration-over 91% institutional ownership as of mid-2025-as a sign of stability, but it also means the stock's movement is heavily tied to the systematic flows of large asset managers. This is not a retail-driven stock; it's a professional-grade holding.
The key players are the passive investment giants, BlackRock and Vanguard. They buy and hold CTS Corporation primarily because it's included in major market indexes, not because of a specific activist thesis. Their influence is felt mostly through governance and proxy votes, not through public campaigns demanding a sale or a strategy pivot. Honestly, that high concentration of institutional capital acts like a floor under the stock, but it also limits the potential for a quick, activist-driven pop.
Notable Investors and Their Stakes
The top institutional holders are a familiar list of index fund and large mutual fund managers. BlackRock, Inc. and Vanguard Group Inc. alone control a significant portion of the outstanding shares. Here's the quick math on the top five holders based on their most recent 13F filings from the third quarter of 2025:
| Institution | Shares Held (as of Sep 30, 2025) | Ownership Percentage | Value (Approximate) |
|---|---|---|---|
| BlackRock, Inc. | 4,334,951 | 14.7% | ~$173 million |
| Vanguard Group Inc. | 2,709,134 | 9.2% | ~$108 million |
| Earnest Partners LLC | 1,868,990 | 6.3% | ~$75 million |
| Wasatch Advisors LP | 1,793,542 | 6.1% | ~$72 million |
| T. Rowe Price Investment Management, Inc. | 1,653,201 | 5.6% | ~$66 million |
Note: The approximate values are based on the share price near the filing date of September 30, 2025, which was around $39.94 per share. BlackRock's stake, for instance, is worth about $173 million. These are huge, passive positions that signal confidence in the long-term, index-driven performance of the electronics sector.
Investor Influence: Governance Over Activism
The influence of these investors is substantial, but it's mostly a quiet power. When BlackRock or Vanguard file a Schedule 13G, they are declaring a passive intent-they aren't looking to shake up management. Their focus is on good corporate governance, making sure the company's long-term strategy aligns with sustainable returns. You can see this focus in the company's own stated goals, such as those outlined in their Mission Statement, Vision, & Core Values of CTS Corporation (CTS).
What this means for company decisions is that management has a long leash, provided they deliver consistent results and maintain strong environmental, social, and governance (ESG) practices. If performance falters, these large index funds will use their immense voting power on proxy issues, potentially pushing for changes to the board or executive pay. It's a governance check, not a strategic overhaul.
Recent Moves: Q3 2025 Buying and Selling
Looking at the third quarter of 2025, we saw some defintely notable shifts among the top holders, which tells you how fund managers are viewing CTS Corporation's near-term prospects. These moves are crucial because they affect the stock's supply and demand dynamics.
- BlackRock, Inc. reduced its position by 228,209 shares in Q3 2025. This was a strategic portfolio adjustment, not a fire sale, but it shows a slight cooling of conviction at the margin.
- T. Rowe Price Investment Management, Inc. made a significant cut, reducing its stake by over 19% (about 388,060 shares) in August 2025. This is a clear move by an active manager to reallocate capital, likely due to a reassessment of CTS Corporation's growth trajectory or valuation.
- Wasatch Advisors LP, an active fund, went the other way, increasing its stake by 84,877 shares in the same quarter. This suggests an active manager sees a compelling buying opportunity or a positive outlook for the company's sensor and component markets.
- Vanguard Group Inc. showed a minor increase of 12,421 shares, which is typical for a passive fund that is simply tracking a slightly larger index weighting.
The key takeaway is that active managers like T. Rowe Price are trimming, while others like Wasatch are buying, creating a tug-of-war that keeps the stock price range-bound. Your action here is to watch which way the active money flows in Q4 2025; that will signal the market's consensus on the company's ability to hit its full-year 2025 sales guidance of $520 million to $550 million.
Market Impact and Investor Sentiment
You're looking at CTS Corporation (CTS) and trying to figure out if the big money is buying or running. Honestly, the sentiment among major shareholders is best described as a high-conviction tug-of-war, which leaves the stock in a neutral-to-cautiously-positive holding pattern.
The core of the investor base is defintely institutional; as of mid-2025, a massive 91.56% of the company's shares, valued at about $1.17 billion, are held by institutions like BlackRock, The Vanguard Group, and Earnest Partners. That level of institutional commitment is a strong vote of confidence in the long-term story, especially the push into diversified markets like medical and industrial. Big money is already in, and it's not going anywhere fast.
But the near-term picture is mixed. In the most recent quarter, 100 institutional funds decreased their positions, slightly outweighing the 88 that added shares. For example, T. Rowe Price Investment Management, Inc. removed 176,743 shares in Q1 2025, while AMERIPRISE FINANCIAL INC added a significant 142,863 shares. That's a classic institutional rotation-some are taking profits or rebalancing, and others are establishing new positions based on the company's strategic pivot.
- BlackRock holds the largest stake: 15.27%.
- Insider sentiment is negative due to open-market selling.
- High institutional ownership stabilizes the long-term outlook.
Recent Market Reactions to Capital Moves
The stock market is a fickle beast, but CTS Corporation's recent capital allocation moves have provided a much-needed stabilizer. The company's focus on returning capital to shareholders is a clear signal to the market that management sees value in its own stock. In November 2025, CTS Corporation announced a new $100 million share repurchase program, which is a substantial move for a company with a market capitalization around $1.21 billion.
This commitment, plus strong Q2 2025 results, helped the stock. When CTS Corporation reported its Q2 2025 earnings, beating analyst forecasts with revenue of $135.3 million, the stock price immediately jumped 3.39%. More recently, the stock saw a strong 6.76% return in the 30 days leading up to mid-November 2025, suggesting a stabilization of sentiment after a negative 18.39% year-to-date return. The market is rewarding capital discipline and diversification, but it's still cautious.
The market is slowly starting to buy the diversification story, but it's still pricing in the transportation risk. For a deeper dive into the company's history and core business model, you can check out CTS Corporation (CTS): History, Ownership, Mission, How It Works & Makes Money.
Analyst Perspectives: Pricing in Diversification
Wall Street analysts are generally on the fence, with a consensus 'Hold' rating, but their price targets suggest a clear upside from recent trading levels. The most recent analyst price targets range up to $47.00, which is what some valuation models suggest as the fair value. Here's the quick math: a fair value of $47.00 compared to a recent close of around $42.35 suggests the stock is approximately 9.9% undervalued, according to one popular narrative.
The key driver for this optimism is the company's successful pivot. For the third quarter of 2025, sales to diversified end markets-aerospace/defense, industrial, and medical-grew by a strong 22% year-over-year, even as the transportation segment declined by 7%. This strategic shift is what analysts are watching, and it's the main reason for the positive price targets, despite the overall 'Hold' rating.
Here's a snapshot of the company's 2025 fiscal year performance and guidance, which forms the basis of analyst models:
| Metric | Q3 2025 Result | Full-Year 2025 Guidance (Narrowed) |
|---|---|---|
| Sales | $143 million | $535 million - $545 million |
| Net Income | $14 million | N/A |
| Adjusted Diluted EPS | $0.60 | $2.20 - $2.25 |
What this estimate hides is the persistent weakness in the transportation sector, which remains the single biggest near-term risk. Analysts expect this diversification momentum to continue, projecting 2026 revenues of approximately $561.5 million. So, the action item for you is to watch for continued outperformance in those diversified markets; that's the only thing that will turn the 'Hold' into a 'Buy.'

CTS Corporation (CTS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.